Recall of TIROSINT® SOL (levothyroxine sodium) Oral Solution
On March 1, 2023, the U.S. Food and Drug Administration (FDA) announced that IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution as a Class I Recall due to the medicine not being strong enough.
Please note that not all lots are affected, so you may not be affected by this recall. Your health and safety are important to us. If you are currently taking TIROSINT®-SOL (levothyroxine sodium) Oral Solution, please call your health care provider to talk about other treatment or medicine that may be appropriate.
For more information, please visit FDA.gov, or call IBSA Pharma Inc. at 1-800-587-3513 (TTY 711), weekdays, 9 a.m. to 7 p.m., Eastern Time (ET). You can also call the Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016 (TTY 711), weekdays, 8 a.m. to 5 p.m., ET.